# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105026
Filing Date
2025-08-07
Accepted
2025-08-07 16:11:36
Documents
72
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bdsx-20250630.htm iXBRL | 10-Q | 2522133
2 | EX-31.1 | bdsx-ex31_1.htm | EX-31.1 | 15990
3 | EX-31.2 | bdsx-ex31_2.htm | EX-31.2 | 16008
4 | EX-32.1 | bdsx-ex32_1.htm | EX-32.1 | 9056
5 | EX-32.2 | bdsx-ex32_2.htm | EX-32.2 | 9281
| Complete submission text file | 0000950170-25-105026.txt |  | 11281911

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | bdsx-20250630.xsd | EX-101.SCH | 1840874
75 | EXTRACTED XBRL INSTANCE DOCUMENT | bdsx-20250630_htm.xml | XML | 1950066

Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 251194112
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)